Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Oct;52(10):1531.
doi: 10.1136/gut.52.10.1531-a.

Complete regression of advanced HCC with long acting octreotide

J T Siveke, C Herberhold, C Folwaczny
Comment

Complete regression of advanced HCC with long acting octreotide

J T Siveke et al. Gut. 2003 Oct.

Erratum in

  • Gut. 2003 Dec;52(12):1800
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kouroumalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 1998;42:442–7. - PMC - PubMed
    1. Yuen MF, Poon RT, Lai CL, et al. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology 2002;36:687–91. - PubMed
    1. Reubi JC, Waser B, Schaer JC, et al. Somatostatin receptor sst1- sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836–46. - PubMed
    1. Reubi JC, Zimmermann A, Jonas S, et al. Regulatory peptide receptors in human hepatocellular carcinomas. Gut 1999;45:766–74. - PMC - PubMed
    1. Benali N, Cordelier P, Calise D, et al. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci USA 2000;97:9180–5. - PMC - PubMed

MeSH terms

Substances